With Obamacare now law, PhRMA, it seems, can breathe a sigh of relief. Their $80 billion deal with the Obama administration held. Not so fast, says Sen. Byron Dorgan (D., N.D.). He tells NRO that he “intends” to offer an amendment in the near future to allow prescription-drug imports. “It became clear that I didn’t have the votes on the health-care reform bill, but there are not any agreements beyond that.”